1-(4-fluorobenzoyl)-3-(piperid-4-yl)urea | 72807-14-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-fluorobenzoyl)-3-(piperid-4-yl)urea
• 英文别名: 4-(4-Fluorobenzoylureido)piperidine；4-fluoro-N-(piperidin-4-ylcarbamoyl)benzamide
• CAS: 72807-14-8
• 化学式: C₁₃H₁₆FN₃O₂
• 分子量: 265.287
• InChiKey: GMTDTFQBVHLRCF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  70.2
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(4-fluorobenzoyl)-3-(piperid-4-yl)urea 、 2-bromo-1-(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)ethanol 在 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 1-{1-[2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-2-hydroxy-ethyl]-piperidin-4-yl}-3-(4-fluoro-benzoyl)-urea
  参考文献：
  名称：

  降压脲基哌啶。

  摘要：

  报道了一系列1-芳烷基-4-脲基哌啶的合成。这些化合物与吲哚胺为例的苯甲酰氨基哌啶有关。一些脲基哌啶比其苯甲酰氨基哌啶具有更强的抗高血压药。两个例子，1-（2-thenoyl）-3- [1- [2-（3-吲哚基）乙基]哌啶-4-基]脲和1-（2-thenoyl）-3- [1- [4- （4-氟苯基）-4-氧代丁基]哌啶-4-基]脲（19和58）成为本系列中最有效的降压药。

  DOI：

  10.1021/jm00182a009

文献信息

• Piperidino ureas and thioureas
  申请人：John Wyeth & Brother Limited

  公开号：US04281132A1

  公开（公告）日：1981-07-28

  Compounds of formula ##STR1## in which X represents oxygen or sulphur; Y represents --CHOH-- or ##STR2## Z represent ##STR3## or a direct bond; R represents cycloalkyl group having 5 to 7 carbon atoms or an optionally substituted aryl or heteroaryl radical, or when --Z-- is a direct bond R also represents hydrogen; R.sup.1 represents hydrogen or lower alkyl; R.sup.2 represents hydrogen, halogen, lower alkyl or lower alkoxy; and R.sup.3 represents hydrogen or lower alkyl, and a pharmaceutically acceptable acid addition or quarternary ammonium salts thereof, are disclosed which possess hypotensive activity.

  该公式化合物中，X代表氧或硫；Y代表--CHOH--或Z代表##STR3##或直接键；R代表具有5到7个碳原子的环烷基团或可选择取代的芳基或杂环芳基基团，或当--Z--为直接键时，R也代表氢；R.sup.1代表氢或较低的烷基；R.sup.2代表氢、卤素、较低的烷基或较低的烷氧基；R.sup.3代表氢或较低的烷基，以及其药用酸盐或季铵盐，具有降压活性。
• Anti-depressant indole derivatives
  申请人：John Wyeth & Brother Limited

  公开号：US04209521A1

  公开（公告）日：1980-06-24

  The invention concerns a compound of formula II ##STR1## or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof wherein R.sup.5 represents hydrogen, hydroxy, lower alkoxy or lower alkyl, R.sup.6 represents hydrogen or lower alkyl, and R.sup.7 represents phenyl, lower alkoxy phenyl, halophenyl, or thenyl and X represents oxygen or sulphur. These indole derivatives exhibit psychotropic activity. The invention includes a method of alleviating depression in a warm blooded animal afflicted with depression which method comprises administering to said animal an effective amount of a compound of formula II or a pharmaceutically acceptable acid addition salt thereof.

  本发明涉及II式化合物，其中R.sup.5代表氢，羟基，较低的烷氧基或较低的烷基；R.sup.6代表氢或较低的烷基；R.sup.7代表苯基，较低的烷氧基苯基，卤代苯基或蒽基；X代表氧或硫。这些吲哚衍生物具有精神活性。本发明包括一种方法，用于缓解患有抑郁症的温血动物的抑郁症状，该方法包括向该动物施用II式化合物或其药学上可接受的酸加成盐的有效量。
• Indole derivatives, their preparation and use in pharmaceutical compositions
  申请人：JOHN WYETH & BROTHER LIMITED

  公开号：EP0002886A2

  公开（公告）日：1979-07-11

  The invention concerns a compounds of formula II or an acid addition or quaternary ammonium salt thereof wherein R5 represents hydrogen, hydroxy. lower alkoxy or lower alkyl. R6 represents hydrogen or lower alkyl, and R represents phenyl, lower alkoxy phenyl, halophenyl, or thenyl and X represents oxygen or sulphur. The invention includes pharmaceutical compositions containing the novel indole derivatives and processes for their preparation. These indole derivatives exhibit psychotropic activity.

  本发明涉及式 II 的化合物 或其酸加成盐或季铵盐 其中 R5 代表氢、羟基、低级烷氧基或低级烷基。R6代表氢或低级烷基，R代表苯基、低级烷氧基苯基、卤代苯基或芳基，X代表氧或硫。本发明包括含有新型吲哚衍生物的药物组合物及其制备工艺。这些吲哚衍生物具有精神活性。
• Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives
  申请人：JOHN WYETH & BROTHER LIMITED

  公开号：EP0035374A2

  公开（公告）日：1981-09-09

  The invention concerns psychotropic agents useful as antidepressants having the formula and acid addition and quaternary ammonium salts thereof, wherein the dotted line represents an optional bond, Ar represents a ring system of formula in which Q is O,S,-CR7=CR8- and -N=N-; R4, R5 and R6, and R7 and R8 when present, each represent hydrogen or defined substituents and additionally either R4 and R5 when adjacent or R6 and R8 when adjacent, together with the carbon atoms to which they are attached also represent a fused five or six membered carbocyclic or heterocyclic ring optionally carrying one or more defined substituents; R is an optionally substituted aryl or heteroaryl radical or a cycloalkyl radical containing 5 to 7 carbon atoms; R1, R2, R3 and R9 are each hydrogen or a lower alkyl group; n is 0 or 1; X is =0, =S or =NH; Y is -O- or a direct bond and Z is -CO- or -CH2- with the proviso that when Ar is unsubstituted phenyl and R9 is hydrogen then Y is -0-. Processes for preparing the compounds and pharmaceutical compositions containing them are also disclosed. Analogues having a pyridinium ring or ZR representing hydrogen are also disclosed as intermediates.

  本发明涉及可用作抗抑郁剂的精神药物，其化学式为 及其酸加成盐和季铵盐，其中虚线代表任选键，Ar 代表式 其中 Q 是 O、S、-CR7=CR8- 和 -N=N-；R4、R5 和 R6 以及 R7 和 R8（当存在时）各自代表氢或定义的取代基，此外，R4 和 R5（当相邻时）或 R6 和 R8（当相邻时）与它们所连接的碳原子一起还代表可选带一个或多个定义取代基的融合的五或六成员碳环或杂环；R是任选取代的芳基或杂芳基或含有5至7个碳原子的环烷基；R1、R2、R3和R9各自是氢或低级烷基；n是0或1；X是＝0、＝S或＝NH；Y是-O-或直接键，Z是-CO-或-CH2-，但当Ar是未取代的苯基且R9是氢时，则Y是-0-。 此外，还公开了制备这些化合物和含有这些化合物的药物组合物的工艺。还公开了具有吡啶鎓环或 ZR 代表氢的类似物作为中间体。
• ARCHIBALD J. L.; BEARDSLEY D. R.; BISSET G. M.; FAIRBROTHER P.; JACKSON J+, J. MED. CHEM., 1980, 23, NO 8, 857-861
  作者：ARCHIBALD J. L.、 BEARDSLEY D. R.、 BISSET G. M.、 FAIRBROTHER P.、 JACKSON J+

  DOI：——

  日期：——